These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
344 related items for PubMed ID: 25009196
1. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. Buckley A, McQuaid S, Johnson P, Buggy DJ. Br J Anaesth; 2014 Jul; 113 Suppl 1():i56-62. PubMed ID: 25009196 [Abstract] [Full Text] [Related]
2. Differential effects of serum from patients administered distinct anaesthetic techniques on apoptosis in breast cancer cells in vitro: a pilot study. Jaura AI, Flood G, Gallagher HC, Buggy DJ. Br J Anaesth; 2014 Jul; 113 Suppl 1():i63-7. PubMed ID: 25009197 [Abstract] [Full Text] [Related]
11. Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery. Verma C, Kaewkangsadan V, Eremin JM, Cowley GP, Ilyas M, El-Sheemy MA, Eremin O. J Transl Med; 2015 Jun 04; 13():180. PubMed ID: 26040463 [Abstract] [Full Text] [Related]
14. Effect of Equipotent Doses of Propofol versus Sevoflurane Anesthesia on Regulatory T Cells after Breast Cancer Surgery. Oh CS, Lee J, Yoon TG, Seo EH, Park HJ, Piao L, Lee SH, Kim SH. Anesthesiology; 2018 Nov 04; 129(5):921-931. PubMed ID: 30074934 [Abstract] [Full Text] [Related]
16. Serum NETosis expression and recurrence risk after regional or volatile anaesthesia during breast cancer surgery: A pilot, prospective, randomised single-blind clinical trial. Aghamelu O, Buggy P, Smith G, Inzitari R, Wall T, Buggy DJ. Acta Anaesthesiol Scand; 2021 Mar 04; 65(3):313-319. PubMed ID: 33187020 [Abstract] [Full Text] [Related]
19. Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy. Muraro E, Comaro E, Talamini R, Turchet E, Miolo G, Scalone S, Militello L, Lombardi D, Spazzapan S, Perin T, Massarut S, Crivellari D, Dolcetti R, Martorelli D. J Transl Med; 2015 Jun 27; 13():204. PubMed ID: 26116238 [Abstract] [Full Text] [Related]
20. Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial. Woo JH, Baik HJ, Kim CH, Chung RK, Kim DY, Lee GY, Chun EH. J Korean Med Sci; 2015 Oct 27; 30(10):1503-8. PubMed ID: 26425050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]